Showing 4731-4740 of 5059 results for "".
New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21558/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21616/New products and pharmacologic developmentsNew products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21688/Laser Pulse
https://practicaldermatology.com/issues/supplements/laser-pulse/21986/Updates on the latest developments in devices, lasers, and light technologiesDermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.The Contract: A Tool for Mapping the Future
https://practicaldermatology.com/topics/general-topics/the-contract-a-tool-for-mapping-the-future/22023/Many physician extenders focus on compensation and benefits without recognizing the importance of the contract in anticipating the “What ifs” in practice.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0809_06-php/22785/Is Topical Therapy for Psoriasis Resurging?
https://practicaldermatology.com/topics/psoriasis/PD0409_03-php/22841/While biologics have changed the way patients and physicians think about psoriasis, topical therapy remains important for a majority of patients.Joel Schlessinger MD Explains How a Spa Helped Build His Practice
https://practicaldermatology.com/topics/practice-management/joel-schlessinger-md-explains-how-a-spa-helped-build-his-practice-/19156/As the dermatology and skin care industry expands, the opportunity to offer new procedures, techniques and products for your patients grows. One way that Joel Schlessinger MD chose to advance his business was by adding a spa on to his current practice. In this video, he explains how the decision helDiverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into why